qPCRqPCR Services for Research, Drug Development & Clinical Validation

From custom assay development and optimization to fit-for-purpose validation and high-throughput sample analysis, SCD provides quantitative PCR services designed around your target, sample type, and study requirements. Our molecular biology specialists support exploratory research, preclinical development, and regulated bioanalysis through our laboratory in Gothenburg, Sweden.

GLP accredited by SWEDAC.

Request a QuoteBook a Call

qpcr scientist quality control
Trusted By
Quality assurance & compliance

We are accredited for Good Laboratory Practice (GLP) by the Swedish Board for Accreditation and Conformity Assessment (SWEDAC) for qPCR, dPCR, and molecular biology.

About qPCR

Quantitative PCR Services at SCD

Quantitative polymerase chain reaction (qPCR) enables sensitive measurement of specific DNA targets and, following reverse transcription, RNA targets. It supports applications ranging from gene expression and biomarker studies to vector biodistribution, shedding, and clinical sample analysis. At SCD, we develop, optimize, qualify, validate, and perform qPCR assays to meet each study's intended use. Our teams help select an appropriate analytical strategy, establish controls, evaluate performance, and translate measurements into interpretable results.

Our qPCR services are delivered through our Gothenburg laboratories, formerly known as TATAA Biocenter, now TATAA, an SCD company.

  • Custom assay development: target-specific primer and probe design, feasibility assessment, and optimization.
  • Research-to-regulated workflows: fit-for-purpose qualification and, where applicable, GLP/GCLP-aligned validation and sample analysis.
  • Scalable analysis: singleplex or compatible multiplex assays using 96- and 384-well formats.
Specifications

qPCR Specifications & Technical Capabilities

An overview of our qPCR capabilities. Final assay configuration and regulatory scope are defined during project scoping.

Specification Details
Technology Real-time quantitative PCR (qPCR); RT-qPCR for RNA targets
Target material DNA; RNA following reverse transcription to cDNA
Sample inputs Extracted nucleic acids from tissue, biofluids, and other qualified biological matrices
Quantification Absolute quantification with calibrated standards; relative quantification with suitable reference genes and controls
Assay formats Singleplex and multiplex, where compatible
Detection chemistry Probe-based and dye-based approaches, including TaqMan and SYBR Green, subject to assay suitability
Throughput 96- and 384-well formats
Instrumentation QuantStudio™ 7 Pro Real-Time PCR System (Applied Biosystems™, Thermo Fisher Scientific)
Development Primer/probe design, extraction and RT optimization, assay feasibility and performance evaluation
Validation characteristics As relevant to intended use: specificity, sensitivity, accuracy, precision, linearity, range, and robustness
Quality framework Research Use Only (RUO), qualified, or validated GLP/GCLP workflows as applicable to the specific study and laboratory scope
Deliverables Quantitative results, QC summary, method details, and validation documentation as agreed
Assay development

Custom qPCR Assay Development & Validation

A reliable qPCR assay begins with a method designed for its specific target, biological matrix, and intended use. Our scientists consider the full analytical workflow, from extraction and reverse transcription to amplification, data processing, and reporting, rather than treating PCR as an isolated step.

Every assay is evaluated experimentally. Extraction recovery, nucleic acid integrity, reverse transcription efficiency, amplification efficiency, matrix effects, and primer/probe specificity can all influence performance. For advanced therapy applications, factors such as free versus encapsidated AAV DNA, target length, nucleic acid modifications, and secondary structures may require additional assessment.

What our assay development service includes

  • Study design and target selection: define analytes, specimen types, expected concentrations, and reporting requirements.
  • Sample preparation: assess extraction recovery and, for RNA assays, reverse transcription performance.
  • Primer and probe design: develop or evaluate target-specific assays and assess potential interference.
  • Reaction optimization: evaluate chemistry, cycling conditions, amplification efficiency, specificity, and assay range.
  • Qualification and validation: establish and test performance characteristics and acceptance criteria appropriate to the intended use.

Need a Custom-Developed or Validated Assay?

From assay design and optimization to method validation, our scientists develop fit-for-purpose molecular assays tailored to your research and regulatory requirements.

Explore Method Development & Validation

Quality control

Quality Control Throughout the qPCR Workflow

Reliable quantitative results depend on controls at every stage. We design QC strategies to detect contamination, monitor recovery and assay efficiency, and establish whether reported results meet predefined requirements.

  • Extraction and RT controls: appropriate spike-in materials or external nucleic acid controls can help assess recovery and RT inhibition.
  • No-RT controls: for RNA workflows, reactions without reverse transcriptase help identify genomic DNA interference.
  • No-template controls (NTCs): included to monitor reagent and reaction contamination.
  • Calibration standards and QC samples: known concentrations are used, where appropriate, to evaluate assay range, precision, accuracy, and standard curve performance.
  • Run acceptance criteria: in validated assays, QC samples, calibration curves, negative controls, and sample replicates are assessed against predefined assay-specific criteria.
  • Operational controls: reagent stability and storage conditions, instrument calibration, and documented procedures support consistent analysis.

The precise control panel and acceptance thresholds depend on the assay, matrix, intended use, and applicable quality framework. No universal CV%, RE%, R², or efficiency threshold should be implied across all qPCR methods.

qPCR workflow

From Study Design to Results

Consultation
Feasibility &
assay design
Execution & QC
Analysis &
reporting
Person having online consultation
Step 1

Scientific consultation

We define your biological question, analyte, sample matrix, sample numbers, expected range, development stage, and required deliverables. We also identify any regulatory or documentation requirements.

SORT-seq and VASA-seq cell capture plates move through a pipetting robot
Step 2

Feasibility and assay design

We review sample characteristics, extraction and RT requirements, assay chemistry, primer/probe strategy, and relevant controls. Feasibility work informs the proposed method and validation plan.

Single Cell Discoveries lab
Step 3

Method execution and quality control

Our laboratory performs assay development, optimization, qualification or validation as agreed, followed by sample analysis. We monitor run performance against the appropriate predefined QC criteria.

Person loading Illumina NextSeq2000
Step 4

Data analysis and reporting

We review amplification data, calibration and normalization approaches, sample-level QC, and quantitative results. Your team receives agreed outputs and sufficient methodological context to interpret findings and plan next steps.

Applications

qPCR Applications in Drug Development

qPCR is used across discovery, translational research, and drug development wherever sensitive, target-specific nucleic acid measurement is required.

Gene Expression & Biomarker Analysis

Measure relative changes in gene expression, verify transcriptomic findings, and monitor selected biomarkers across treatment groups or time points.

AAV and Cell & Gene Therapy Studies

Support vector copy number, biodistribution, and shedding investigations through appropriately developed assays for relevant vector or transgene targets.

RNA Therapeutics & Molecular Targets

Quantify selected RNA-derived targets using RT-qPCR workflows designed around RNA integrity, extraction recovery, reverse transcription, and intended analytical use.

Clinical and Longitudinal Sample Analysis

Apply qualified or validated methods to selected biomarkers and nucleic acid targets in serial samples, where the assay and laboratory quality framework support the study requirements.

Our expertise

Decades of qPCR Expertise, Backed by International Standards

Formerly TATAA Biocenter

Our qPCR services are performed at SCD’s laboratories in Gothenburg, Sweden, at TATAA Biocenter, now TATAA, an SCD company. This team brings established expertise in molecular assay development, quality control, and regulated bioanalysis into SCD’s broader discovery-to-validation service portfolio.

TATAA contributed to the internationally recognized MIQE guidelines (Minimum Information for Publication of Quantitative Real-Time PCR Experiments), which promote transparent, reproducible qPCR study design, analysis, and reporting. These principles inform our approach to assay controls, performance evaluation, and documentation.

In 2024, TATAA also contributed to the publication “Recommendations for Method Development and Validation of qPCR and dPCR Assays in Support of Cell and Gene Therapy Drug Development,” developed with experts across the sector. The paper addresses practical considerations for assays supporting advanced therapy development.

Together with SCD’s single-cell, spatial, sequencing, and data science services in the Netherlands, our Gothenburg capabilities enable complementary discovery and targeted validation studies within one organization. We confirm the applicable GLP/GCLP scope and site-specific accreditation status for each project.

25+
Years of qPCR expertise

Building on TATAA's molecular biology experience since 2001

384
Well plate format

For high-throughput quantitative analysis

GLP
Accredited laboratory

SWEDAC-accredited qPCR capabilities in Gothenburg

How it works

Understanding qPCR: Technology & Quantification Methods

What is qPCR?

Quantitative PCR measures amplification of a selected nucleic acid target in real time using a fluorescent probe or dye. Fluorescence is recorded across PCR cycles, and the quantification cycle (Cq) indicates when the signal crosses a defined threshold. Under comparable assay conditions, a lower Cq generally corresponds to a greater starting amount of target nucleic acid.

For RNA targets, reverse transcription converts RNA to cDNA before amplification (RT-qPCR). Quantitative interpretation depends on the method, assay efficiency, calibration or normalization strategy, and appropriate quality controls.

Comparison

Absolute vs. Relative qPCR Quantification

Absolute quantification Relative quantification
Estimates target quantity using calibrated standards and a standard curve. Compares normalized target abundance between samples or conditions.
Results may be reported in copies per reaction, copies/µL, or other defined units. Results are typically expressed as fold changes or relative expression.
Common for vector DNA, viral targets, and copy-number measurements. Common for gene expression and biomarker response studies.
Performance depends on standard quality and assay efficiency. Performance depends on reference-gene stability, assay efficiency, and control selection.

qPCR vs. dPCR: Which Method Fits Your Study?

qPCR is well suited to established, scalable target quantification and comparative expression studies. Digital PCR (dPCR) partitions reactions and can provide absolute target quantification without a conventional standard curve, making it useful for selected low-abundance or high-precision applications. The best choice depends on target concentration, required sensitivity and precision, sample matrix, throughput, and regulatory context.

Explore our Digital PCR (dPCR) services.

Wondering if this service can
help answer your biological question?

Request a quote today and find out how our expertise can support your research.

Request quotation

What our clients say

Prof. Dr. Stella Autenrieth, Research Group Leader at German Cancer Research Center

"The service of Single Cell Discoveries guarantees a smooth process between customer and company. In case of problems or questions, the scientists reacted competently and immediately, so that answers could be found quickly and flexibly."

Samuel García Pérez, Principal Investigator at Galicia Sur Health Research Institute

"Fantastic job made by a really professional and friendly team. I strongly recommend Single Cell Discoveries for sequencing services."

Recent publications using qPCR

Case studies

Amsterdam UMC

Pioneering 10x Flex on OCT-Embedded Patient Brain Tissue

10x Genomics opened the gates for single-cell sequencing on non-fresh, non-thawed tissue with their Chromium Single Cell Gene Expression Flex (10x Flex) kit. Now, we have been successful in performing…

10x
Neuroscience
Neuroscience
RNA Flex

Recent blogs related to qPCR

Frequently Asked Questions
What is the difference between qPCR and RT-qPCR?

qPCR measures DNA targets during amplification. RT-qPCR includes a reverse-transcription step that converts RNA into cDNA before quantitative amplification, making it suitable for RNA expression and other RNA-target analyses.

Request a quote

Discuss Your qPCR Project With Our Scientists

Whether you need to develop a new assay, validate an existing method, or analyze samples at scale, our molecular biology specialists can help define a fit-for-purpose qPCR strategy. Tell us about your target, sample type, study stage, and reporting requirements, and we will discuss the most appropriate next steps.

REQUEST A QUOTEBook a Call

Your details - Step 1 of 2